Real-world safety and outcomes of a new heart stent
Part of Heart & circulation clinical trials.
This study looks at patients who received a special type of heart stent (a small mesh tube that holds open a blocked artery) during a procedure called angioplasty at Geneva University Hospitals. The goal is to see how safe and effective this stent is in everyday practice.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older at the time of the heart procedure.
- You had a heart angioplasty (a procedure to open blocked arteries) at Geneva University Hospitals between January 2021 and December 2025.
- During that procedure, you received at least one of the study stents, which is a small device that keeps the artery open.
- You are willing and able to give written permission to be part of this study.
- You can understand French, German, English, or Italian well enough to read the study information.
- You have not chosen to opt out of research, can be contacted for consent, and are expected to live at least 12 more months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new stent (a small mesh tube) to open narrowed heart arteries and improve blood flow. It may help people with multiple blocked arteries who are having a procedure to widen them.
This trial tests a new type of stent (a small mesh tube) that slowly releases a medicine called sirolimus to keep your heart artery open after angioplasty. It is designed for people with narrowing in their heart arteries who need a stent.
This trial is testing a new type of stent (a small tube that props open a narrowed heart artery) coated with a medicine called everolimus to keep the artery open. The study wants to see if the stent is safe and works well for people with coronary artery disease, which is narrowing of the heart's blood vessels.
This trial tests a stent that slowly dissolves after opening a blocked heart artery, releasing a drug to prevent reclogging. It may help people with narrowing in one or two spots that are not too hard or twisted.
This trial tests a new type of stent made from magnesium that slowly dissolves over time. It is for people who have a long blockage in a heart artery that has not been treated before and may be a good option for those who are stable and have not had a recent heart attack.
This study compares two types of devices used to open blocked heart arteries during a heart attack or unstable chest pain: one is a scaffold made of magnesium that dissolves over time, the other is a permanent stent with a coating that releases medicine. The goal is to see which device works better for patients like you.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.